title: Immunosuppression and the prognosis of patients suffering from myeloproliferative disorders after liver transplantation.
authors.affiliation: Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Carl-Neuberg-Strasse 1, 30623 Hannover, Germany. matthias.bahr@gmx.de
authors.forename: Matthias J
authors.initials: MJ
authors.lastname: Bahr
authors.forename: J
authors.initials: J
authors.lastname: Rosenau
authors.forename: U J F
authors.initials: UJ
authors.lastname: Tietge
authors.forename: M
authors.initials: M
authors.lastname: Caselitz
authors.forename: M W
authors.initials: MW
authors.lastname: Hofmann
authors.forename: J
authors.initials: J
authors.lastname: Klempnauer
authors.forename: K H W
authors.initials: KH
authors.lastname: Böker
authors.forename: C P
authors.initials: CP
authors.lastname: Strassburg
authors.forename: M P
authors.initials: MP
authors.lastname: Manns
mesh_terms: D000328:Adult; D006502:Budd-Chiari Syndrome / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D005858:Germany; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D009196:Myeloproliferative Disorders / Q000453:epidemiology*; D011183:Postoperative Complications / Q000453:epidemiology*; D011379:Prognosis; D012189:Retrospective Studies; D013997:Time Factors